RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
The License Agreement is effective June 27, 2014 and was amended on August 2, 2017.
- The License Agreement is effective June 27, 2014 and was amended on August 2, 2017.
- The Second Amendment is effective December 15, 2022 and was signed by RespireRx and UIL on January 3, 2023 and January 18, 2023 respectively.
- The parties entered into the Second Amendment in order to eliminate accrued financial obligations to UIL and reduce future obligations.
- It is our intention to transfer all of our cannabinoid assets, including the License Agreement and certain liabilities, into ResolutionRx.